South Korea · Delayed Price · Currency is KRW Achilles Therapeutics Statistics
Total Valuation
KRX:264900 has a market cap or net worth of KRW 116.22 billion. The enterprise value is 106.55 billion.
| Market Cap | 116.22B |
| Enterprise Value | 106.55B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:264900 has 12.52 million shares outstanding. The number of shares has decreased by -7.58% in one year.
| Current Share Class | 12.52M |
| Shares Outstanding | 12.52M |
| Shares Change (YoY) | -7.58% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.18% |
| Owned by Institutions (%) | 0.11% |
| Float | 4.80M |
Valuation Ratios
The trailing PE ratio is 7.87 and the forward PE ratio is 6.40.
| PE Ratio | 7.87 |
| Forward PE | 6.40 |
| PS Ratio | 0.26 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | 5.59 |
| P/OCF Ratio | 3.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.22, with an EV/FCF ratio of 5.13.
| EV / Earnings | 7.64 |
| EV / Sales | 0.24 |
| EV / EBITDA | 3.22 |
| EV / EBIT | 5.49 |
| EV / FCF | 5.13 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.43 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | 1.00 |
| Interest Coverage | 17.54 |
Financial Efficiency
Return on equity (ROE) is 7.19% and return on invested capital (ROIC) is 5.20%.
| Return on Equity (ROE) | 7.19% |
| Return on Assets (ROA) | 3.46% |
| Return on Invested Capital (ROIC) | 5.20% |
| Return on Capital Employed (ROCE) | 7.12% |
| Revenue Per Employee | 285.97M |
| Profits Per Employee | 9.09M |
| Employee Count | 1,534 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 9.11 |
Taxes
In the past 12 months, KRX:264900 has paid 4.18 billion in taxes.
| Income Tax | 4.18B |
| Effective Tax Rate | 21.52% |
Stock Price Statistics
The stock price has increased by +2.54% in the last 52 weeks. The beta is 0.57, so KRX:264900's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +2.54% |
| 50-Day Moving Average | 9,201.20 |
| 200-Day Moving Average | 8,393.55 |
| Relative Strength Index (RSI) | 49.77 |
| Average Volume (20 Days) | 20,465 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:264900 had revenue of KRW 438.68 billion and earned 13.95 billion in profits. Earnings per share was 1,179.86.
| Revenue | 438.68B |
| Gross Profit | 138.97B |
| Operating Income | 19.40B |
| Pretax Income | 19.45B |
| Net Income | 13.95B |
| EBITDA | 33.09B |
| EBIT | 19.40B |
| Earnings Per Share (EPS) | 1,179.86 |
Balance Sheet
The company has 30.70 billion in cash and 20.87 billion in debt, giving a net cash position of 9.83 billion or 784.94 per share.
| Cash & Cash Equivalents | 30.70B |
| Total Debt | 20.87B |
| Net Cash | 9.83B |
| Net Cash Per Share | 784.94 |
| Equity (Book Value) | 216.53B |
| Book Value Per Share | 18,006.99 |
| Working Capital | 36.08B |
Cash Flow
In the last 12 months, operating cash flow was 35.61 billion and capital expenditures -14.83 billion, giving a free cash flow of 20.78 billion.
| Operating Cash Flow | 35.61B |
| Capital Expenditures | -14.83B |
| Free Cash Flow | 20.78B |
| FCF Per Share | 1,658.86 |
Margins
Gross margin is 31.68%, with operating and profit margins of 4.42% and 3.48%.
| Gross Margin | 31.68% |
| Operating Margin | 4.42% |
| Pretax Margin | 4.43% |
| Profit Margin | 3.48% |
| EBITDA Margin | 7.54% |
| EBIT Margin | 4.42% |
| FCF Margin | 4.74% |
Dividends & Yields
This stock pays an annual dividend of 280.00, which amounts to a dividend yield of 3.02%.
| Dividend Per Share | 280.00 |
| Dividend Yield | 3.02% |
| Dividend Growth (YoY) | 12.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 23.73% |
| Buyback Yield | 7.58% |
| Shareholder Yield | 10.62% |
| Earnings Yield | 12.00% |
| FCF Yield | 17.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:264900 has an Altman Z-Score of 2.43 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 5 |